Analysis of PBPK models for risk characterization.
- 1 December 1999
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 895 (1), 317-337
- https://doi.org/10.1111/j.1749-6632.1999.tb08093.x
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- An introduction to the use of physiologically based pharmacokinetic models in risk assessmentStatistical Methods in Medical Research, 1997
- Physiological Pharmacokinetic Analysis Using Population Modeling and Informative Prior DistributionsJournal of the American Statistical Association, 1996
- Parameter variability and the interpretation of physiologically based pharmacokinetic modeling results.Environmental Health Perspectives, 1994
- Pharmacogenetics: detecting sensitive populations.Environmental Health Perspectives, 1994
- The Impact of Exercise and Intersubject Variability on Dose Estimates for Dichloromethane Derived from a Physiologically Based Pharmacokinetic ModelFundamental and Applied Toxicology, 1994
- Variability of safe dose estimates when using complicated models of the carcinogenic process A case study: Methylene chlorideFundamental and Applied Toxicology, 1989
- The Use of Pharmacokinetic Models in the Determination of Risks for Regulatory PurposesPublished by Springer Nature ,1989
- Ethnic Differences in Drug MetabolismClinical Pharmacokinetics, 1982
- Variability in target organ deposition among individuals exposed to toxic substancesToxicology and Applied Pharmacology, 1979
- Monte Carlo MethodsPublished by Springer Nature ,1964